DWA
AZN icon

Dorsey Wright & Associates’s AstraZeneca AZN Stock Holding History

Dorsey Wright & Associates’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,364
Closed -$2.49M – 286
2023
Q2 		$2.49M Sell
17,364
-1,761
-9% -$259K 0.75% 67
2023
Q1 		$2.66M Sell
19,125
-1,201
-6% -$162K 0.81% 70
2022
Q4 		$2.76M Buy
+20,326
New +$2.55M 0.8% 53
2021
Q1 		– Sell
-40,499
Closed -$4.05M – 287
2020
Q4 		$4.05M Sell
40,499
-732
-2% -$77.5K 0.6% 39
2020
Q3 		$4.52M Buy
41,231
+717
+2% +$79.7K 0.82% 23
2020
Q2 		$4.3M Sell
40,514
-3,284
-7% -$339K 0.88% 24
2020
Q1 		$3.91M Sell
43,798
-4,980
-10% -$469K 1.48% 15
2019
Q4 		$4.86M Sell
48,778
-1,997
-4% -$188K 1.61% 18
2019
Q3 		$4.53M Sell
50,775
-633
-1% -$54.9K 1.14% 30
2019
Q2 		$4.24M Sell
51,408
-3,242
-6% -$254K 1.03% 37
2019
Q1 		$4.42M Buy
54,650
+461
+0.9% +$36.3K 1.07% 32
2018
Q4 		$4.12M Sell
54,189
-18,878
-26% -$1.47M 1.23% 20
2018
Q3 		$5.78M Buy
+73,067
New +$5.53M 1.05% 43

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Dorsey Wright & Associates's AZN Position: Q3 2023 in Review

Dorsey Wright & Associates sold out of AstraZeneca (AZN) in Q3 2023, closing a stake of 17,364 shares — an estimated $2.49M sold.

Dorsey Wright & Associates first reported a position in AZN in Q3 2018 and held it in 13 quarters. The position peaked at $5.78M in Q3 2018. 1,073 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

  • Dorsey Wright & Associates reported no remaining AstraZeneca position as of Q3 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 17,364 AstraZeneca shares in Q3 2023, an estimated $2.49M.
  • Dorsey Wright & Associates first reported a position in AstraZeneca in Q3 2018 and held it in 13 quarters.
  • Dorsey Wright & Associates's AstraZeneca position peaked at $5.78M in Q3 2018.
  • 1,073 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Dorsey Wright & Associates's 13F filing for Q3 2023, filed 7 Nov 2023.